Reviva pharmaceuticals to present at the h.c. wainwright global investment conference

Cupertino, calif., may 17, 2022 (globe newswire) -- reviva pharmaceuticals holdings, inc. (nasdaq: rvph) (“reviva” or the “company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (cns), cardiovascular, metabolic, and inflammatory diseases, today announced that laxminarayan bhat, ph.d., founder, president, and ceo of reviva will present at the h.c. wainwright global investment conference being held may 23–26, 2022 and invites investors to participate via virtual one-on-one meetings or in-person in miami, fl. please see additional details below:
RVPH Ratings Summary
RVPH Quant Ranking